Clin Oncol. 2011;8(12):711?19. 56. Ogino S, Fuchs CS, Giovannucci E. How many molecular subtypes? Implications with the special tumor principle in personalized medicine. Specialist Rev Mol Diagn. 2012; 12(six):621?28. 57. Ogino S, King EE, Beck AH, et al. Interdisciplinary education to integrate pathology and epidemiology: towards molecular and population-level well being science. Am J Epidemiol. 2012;176(eight):659?67. 58. Kuller LH. Invited commentary: the 21st century epidemiologist–a need for distinct education? Am J Epidemiol. 2012;176(eight):668?71. 59. Ogino S, Beck AH, King EE, et al. Ogino et al. Respond to “The 21st Century Epidemiologist”. Am J Epidemiol. 2012;176(eight):672?74. 60. Hughes LA, Simons CC, van den Brandt PA, et al. Body size, physical activity and danger of colorectal cancer with or without the CpG Island Methylator Phenotype (CIMP). PLoS One. 2011;6(four):e18571. 61. Limsui D, Vierkant RA, Tillmans LS, et al. Postmenopausal hormone therapy and colorectal cancer threat by molecularly defined subtypes amongst older women. Gut. 2012;61(9): 1299?305. 62. Limburg PJ, Limsui D, Vierkant RA, et al. Postmenopausal hormone therapy and colorectal cancer risk in relation to somatic KRAS mutation status amongst older women. Cancer Epidemiol Biomarkers Prev. 2012;21(4):681?84. 63. Gay LJ, Mitrou PN, Keen J, et al. Dietary, life-style and clinico-pathological variables connected with APC mutations and promoter methylation in colorectal cancers from the EPICNorfolk Study. J Pathol. 2012;228(three):405?15. 64. Schernhammer ES, Giovannucci E, Kawasaki T, et al. Dietary folate, alcohol and B vitamins in relation to LINE-1 hypomethylation in colon cancer. Gut. 2010;59(six):794?99. 65. Kuchiba A, Morikawa T, Yamauchi M, et al. Body mass index and danger of colorectal cancer based on fatty acid synthase expression inside the Nurses’ Wellness Study.1398496-40-6 supplier J Natl Cancer Inst. 2012;104(5):415?20. 66. Yamaji T, Iwasaki M, Sasazuki S, et al. Association amongst plasma 25-hydroxyvitamin D and colorectal adenoma according to dietary calcium intake and vitamin D receptor polymorphism.Formula of (S)-3-Fluoropyrrolidine (hydrochloride) Am J Epidemiol. 2012;175(3):236?44. 67. Lubbe SJ, Di Bernardo MC, Broderick P, et al. Complete evaluation with the impact of 14 genetic variants on colorectal68.69. 70. 71.72.73.74.75.76. 77.78.79.80.81. 82. 83.cancer phenotype and risk. Am J Epidemiol. 2012; 175(1):1?0. Shin A, Hong CW, Sohn DK, et al.PMID:24282960 Associations of cigarette smoking and alcohol consumption with advanced or various colorectal adenoma risks: a colonoscopy-based case-control study in Korea. Am J Epidemiol. 2011;174(five):552?62. Chia WK, Ali R, Toh HC. Aspirin as adjuvant therapy for colorectal cancer-reinterpreting paradigms. Nat Rev Clin Oncol. 2012;9(ten):561?70. Diergaarde B, Vrieling A, van Kraats AA, et al. Cigarette smoking and genetic alterations in sporadic colon carcinomas. Carcinogenesis. 2003;24(3):565?71. Satia JA, Keku T, Galanko JA, et al. Eating plan, life-style, and genomic instability inside the North Carolina Colon Cancer Study. Cancer Epidemiol Biomarkers Prev. 2005;14(two): 429?36. Gay LJ, Arends MJ, Mitrou PN, et al. MLH1 promoter methylation, diet program, and way of life variables in mismatch repair deficient colorectal cancer individuals from EPIC-Norfolk. Nutr Cancer. 2011;63(7):1000?010. Ang PW, Loh M, Liem N, et al. Extensive profiling of DNA methylation in colorectal cancer reveals subgroups with distinct clinicopathological and molecular capabilities. BMC Cancer. 2010;10:227. Dahlin AM, Palmqvist R, Henriksson ML, et al. The function with the CpG.